Avanos Medical (AVNS) Finished Goods (2014 - 2026)

Avanos Medical has disclosed Finished Goods across 13 years of filings, most recently posting $78.2 million for Q1 2026.

• Finished Goods for Q1 2026 came in at $78.2 million, up 4.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $78.2 million (up 4.55% YoY), and the FY2025 annual result was $84.0 million, up 7.28% from the prior year.
• Finished Goods came in at $78.2 million for Q1 2026 at Avanos Medical, down from $84.0 million in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $103.4 million in Q1 2023 to a low of $69.8 million in Q4 2022.
• The 5-year median for Finished Goods is $84.0 million (2024), against an average of $83.4 million.
• Across the five-year window, Finished Goods gained 29.57% in 2023 and dropped 18.76% in 2024, its largest moves.
• Avanos Medical's Finished Goods stood at $69.8 million in 2022, then advanced by 26.79% to $88.5 million in 2023, then decreased by 11.53% to $78.3 million in 2024, then climbed by 7.28% to $84.0 million in 2025, then decreased by 6.9% to $78.2 million in 2026.
• The last three Finished Goods figures came in at $78.2 million (Q1 2026), $84.0 million (Q4 2025), and $80.2 million (Q3 2025), per Business Quant data.